137 related articles for article (PubMed ID: 36579988)
1. Relapsed Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Center in Thailand.
Songthawee N; Sripornsawan P; Chavananon S; McNeil EB; Chotsampancharoen T
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4079-4084. PubMed ID: 36579988
[TBL] [Abstract][Full Text] [Related]
2. Relapsed Childhood Acute Lymphoblastic Leukemia: Experience from a Single Tertiary Center in Thailand.
Chotsampancharoen T; Songthawee N; Chavananon S; Sripornsawan P; McNeil EB
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3517-3522. PubMed ID: 36308378
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand.
Songthawee N; Sripornsawan P; Chavananon S; Kittivisuit S; McNeil EB; Chotsampancharoen T
Pediatr Hematol Oncol; 2024; 41(2):150-162. PubMed ID: 38013232
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
5. Identifying Prognostic Factors That Influence Outcome of Childhood Acute Myeloid Leukemia in First Relapse in Saudi Arabia: Results of the Multicenter SAPHOS Study.
Jastaniah W; Bayoumy M; Alsultan A; Al Daama S; Ballourah W; Al-Anzi F; Al Shareef O; Al Sudairy R; Abrar MB; Al Ghemlas I
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):773-780. PubMed ID: 30340992
[TBL] [Abstract][Full Text] [Related]
6. Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol.
Nakayama H; Tabuchi K; Tawa A; Tsukimoto I; Tsuchida M; Morimoto A; Yabe H; Horibe K; Hanada R; Imaizumi M; Hayashi Y; Hamamoto K; Kobayashi R; Kudo K; Shimada A; Miyamura T; Moritake H; Tomizawa D; Taga T; Adachi S
Int J Hematol; 2014 Aug; 100(2):171-9. PubMed ID: 24961644
[TBL] [Abstract][Full Text] [Related]
7. Pediatric relapsed acute myeloid leukemia: a systematic review.
Hoffman AE; Schoonmade LJ; Kaspers GJ
Expert Rev Anticancer Ther; 2021 Jan; 21(1):45-52. PubMed ID: 33111585
[No Abstract] [Full Text] [Related]
8. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
Huang YJ; Zhang JH; Dong CX; Kang JM; Hou YF; Zhang YF; Qi K; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1361-1368. PubMed ID: 36208236
[TBL] [Abstract][Full Text] [Related]
9. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.
Sander A; Zimmermann M; Dworzak M; Fleischhack G; von Neuhoff C; Reinhardt D; Kaspers GJ; Creutzig U
Leukemia; 2010 Aug; 24(8):1422-8. PubMed ID: 20535146
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study].
Li CH; Wei SN; Qiu SW; Gong BF; Gong XY; Li Y; Liu YT; Fang QY; Zhang GJ; Liu KQ; Zhou CL; Lin D; Liu BC; Wang Y; Mi YC; Wei H; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):287-292. PubMed ID: 35680626
[No Abstract] [Full Text] [Related]
11. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
12. [A long-term follow-up study of 82 children with acute myeloid leukemia].
Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
[No Abstract] [Full Text] [Related]
13. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Childhood Acute Myeloid Leukemia in Bulgaria.
Burnusuzov HA; Yordanova MN; Avramova BE; Yurukova NN; Bachvarov KN; Muchinova AB; Vlahova IH; Stoyanova AA; Mumdzhiev IN; Ivanova LR; Spasov NY; Peteva ET; Belcheva MI; Hristozova H; Spasova MI; Kaleva VI; Bobev D; Konstantinov DN
Folia Med (Plovdiv); 2018 Jun; 60(2):234-240. PubMed ID: 30355812
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
[TBL] [Abstract][Full Text] [Related]
16. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission.
Usuki K; Kurosawa S; Uchida N; Yakushiji K; Waki F; Matsuishi E; Kagawa K; Furukawa T; Maeda Y; Shimoyama M; Ago H; Yamano Y; Yano S; Fujishima N; Takamatsu Y; Eto T; Hidaka M; Matsuoka H; Fukuda T
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):444-51. PubMed ID: 22999942
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic Significance of CD45
Sun Q; Zhang HX; Hu CY; Han YH; Bu XT; Li HJ; Li ZY; Yan ZL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):702-707. PubMed ID: 31204919
[TBL] [Abstract][Full Text] [Related]
18. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
19. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG
Pediatr Blood Cancer; 2008 Jan; 50(1):9-16. PubMed ID: 17252564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
